Sep 27, 2022

Blood Cancer Press Kit

The words “you have cancer” are life-changing for everyone impacted by a new diagnosis. AbbVie understands this, and that is why we have joined forces with leading global patient advocates to increase awareness about blood cancers.
Jun 24, 2022

CLL Emotional Impact Report Press Kit

On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.
Jul 02, 2021

AbbVie Corporate Press Kit

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
Mar 31, 2020

AbbVie’s COVID-19 Corporate Giving Press Kit

AbbVie is donating $35 million to help support underserved communities and healthcare systems working to address the impact of the COVID-19 global pandemic.
Mar 21, 2019

AbbVie to Rebuild North Chicago Middle School Press Kit

On March 21, 2019, AbbVie announced a $40 million donation to rebuild Neal Math & Science Academy, North Chicago’s only middle school. This donation builds on our ongoing commitment to the community where we are headquartered globally – North Chicago – and our 6-year partnership to improve student success across the district.